Haemonetics reported $357.76M in Sales Revenues for its fiscal quarter ending in September of 2026.





Sales Change Date
Baxter International USD 2.98B 20M Sep/2026
Becton, Dickinson and Co. USD 5.3B 300M Sep/2026
Boston Scientific USD 5.14B 300M Sep/2026
Cerus USD 50.81M 4.79M Dec/2024
Cooper Companies USD 1.07B 15.3M Jun/2026
Fresenius EUR 5.88B 70M Sep/2026
Fresenius Medical Care EUR 4.94B 80M Sep/2026
Globus Medical USD 763.72M 25.89M Sep/2026
Haemonetics USD 357.76M 18.76M Sep/2026
ICU Medical USD 556.22M 4.54M Sep/2026
Intuitive Surgical USD 3.05B 158.7M Sep/2026
Medtronic USD 9.8B 0 Jun/2026
Merit Medical Systems USD 416.24M 2.56M Sep/2026
Neogen USD 222.8M 2.5M Jun/2026
OraSure Technologies USD 26.76M 322K Dec/2025
Plus Therapeutics USD 1.03M 339K Mar/2026
Quidel USD 618.9M 12M Sep/2026
ResMed USD 1.46B 60M Jun/2026
STAAR Surgical USD 83.4M 10.1M Sep/2026
Steris USD 1.59B 88.6M Sep/2026
Stryker USD 6.5B 100M Sep/2026
Teleflex USD 567.8M 2.5M Sep/2026
Terumo JPY 312.69B 881M Sep/2026
Thermo Fisher Scientific USD 12.14B 147M Sep/2026
US Physical Therapy USD 222.55M 8.45M Sep/2026
Zimmer Biomet Holdings USD 2.06B 120M Sep/2026